Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

James Stevenson, MD

Dr. Stevenson
Cleveland, OH

Dr. James Stevenson

Medical Oncologist

The Cleveland Clinic

9500 Euclid Avenue
Cleveland, OH 44195

Need Help Contacting This Doctor?

Dr. James Stevenson is a medical oncologist and hematologist at the Cleveland Clinic located in Cleveland, Ohio. Dr. Stevenson joined the staff at the Cleveland Clinic in 2012 and in July of 2015 he was appointed Vice Chairman of the Department of Hematology and Medical Oncology.

Dr. Stevenson is part of a team of experts at the Cleveland Clinic’s Taussig Cancer Institute that employs a multidisciplinary approach to the care of patients with lung cancer and mesothelioma. He is responsible for organizing the Multidisciplinary Pleural Mesothelioma Center at the Taussig Cancer Institute where medical and radiation oncologists, pulmonologists, thoracic surgeons, pathologists, and palliative care experts deliver quality care to patients and offer innovative treatments based on the latest research. The goal of the center is to streamline and shorten the time to diagnosis for its patients. Dr. Stevenson’s degree of expertise in his field, as well as his compassion for his patients, is reflected in online reviews by his patients who have said “I would not be alive without Dr. Stevenson and the level of care and concern he has given me” and “…Dr. Stevenson helped save my life and I could not be happier about that.”

Main Specialty: Internal Medicine, Medical Oncology

Other Interests & Specialties: Cancer, lung cancer, mesothelioma, thymic cancer, colorectal cancer, blood disorders, sarcoma, yeloma, lymphoma, chemotherapy, thymic tumors and thymoma.

Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Medical Oncology, Philadelphia Magazine Award, member of the American Society of Clinical Oncology

Education & Experience:

The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma. OncoTargets and Therapy. November 2016;9:7247-7252. doi: 10.2147/OTT.S100214

Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy. Clinical Cancer Research. August 2016;22(15):3791-800. doi: 10.1158/1078-0432.CCR-15-2133

Current issues in malignant pleural mesothelioma evaluation and management. The Oncologist. September 2014;19(9):975-84. doi: 10.1634/theoncologist.2014-0122

Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. Journal of Clinical Oncology. July 2012;30(20):2509-15. doi: 10.1200/JCO.2011.41.5869

Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients. Oncoimmunology. August 2014;2(8):e26218. doi: 10.4161/onci.26218

Mesothelioma Clinical Trials by James Stevenson, MD

Dr. Stevenson is associated with the following clinical trials:

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide